Press Room

2025 AIChE Annual meeting

Start
Sunday, November 02, 2025 - 17:37
End
Thursday, November 06, 2025 - 17:38
Location: Boston, United States

Meet Hovione team at the 2025 AIChE Annual Meeting and find their exciting presentations and Hovione’s latest research and innovations. The AIChE Annual Meeting is an educational forum covering a wide range of topics relevant to cutting-edge research, new technologies, and emerging growth areas in chemical engineering. We look forward to meeting academic and industry experts and exchanging knowledge.

Date: November 2

Oral communication

Title: Early Development of a Modified Release Formulation and Process for Continuous Direct Compression: A Case Study (NH10 case study) 

Presenting Author: Ricardo Sousa, Senior Scientist

3:48 PM - Room 308 (Hynes Convention Center)

Oral communication

Title: Continuous Dosing and Blending (CDB) As a Laboratory Tool to Expedite Process Development

Presenting Author: Ana Costa, Senior Scientist

4:06 PM - Room 308 (Hynes Convention Center)

Oral communication

Title: Exploring Synergies between SMEs and AI-Powered Tools in Reaction Optimization

Presenting Author: Pedro Valente, Fellow Scientist  Modeling & Rapid Prototyping

4:45 PM - Room 309 (Third Level, Hynes Convention Center)



Date: November 3

Poster

Title: GMP Flow Chemistry Platforms: A CDMO Perspective on Enabling the Next Generation of Clinical-Stage API Manufacturing

Presenting Author: Rudi Oliveira, Senior Scientist

3:30 PM - Room Exhibit Hall C (Second Level, Hynes Convention Center)

Oral communication

Title: From offline to inline: Advancing inhalation drug manufacturing with real-time particle size monitoring and solids concentration modelling

Presenting Author: Nichal Gentilal, Scientist

8:54 AM - Room 313 (Hynes Convention Center)

 

Date: November 4

Oral communication

Title: Scaling Down Fluid Bed Drying: A Comparative Study of Mini-Glatt and Consigma™-1

Presenting Author: Ricardo Sousa, Senior Scientist

4:42 PM - Room Liberty Ballroom B (2, Sheraton Boston)

Oral communication

Title: Process development & control strategies with PAT and Soft-sensors: A solvent swap case-study

Presenting Author: Pedro Valente, Fellow Scientist  Modeling & Rapid Prototyping

4:42 PM - Room 309 (Third Level, Hynes Convention Center)

Oral communication

Title: Exploring Novel Excipients in the Transition from Batch to Continuous Tableting (CT)

Presenting Author: Ana Costa, Senior Scientist

4:54 PM - Room 308 (Third Level, Hynes Convention Center)

Oral communication

Title: Safety By Design: Leveraging Data-Rich Experimentation and Process Modeling Towards a Digital Twin

Presenting Author: Rudi Oliveira, Senior Scientist

5:00 PM - Room 309 (Hynes Convention Center)

 

Hovione Team Members will also chair the following sessions:

Nov. 2

Title: Continuous Processing in Drug Product

Presenting Author: Sarang Oka, Fellow Scientist - Technology Intensification  

3:30 PM – Room 308 (Hynes Convention Center)

Nov. 3

Title: Particle Characterization            

Presenting Author: Sarang Oka, Fellow Scientist - Technology Intensification 

8:00 AM - Room Independence Ballroom West

Nov. 3

Title: Advances in Smart Monitoring, Optimization and Control of Process Manufacturing

Presenting Author: Ankita Naik, Modeling and PAT Scientist

8:00 AM - Room 304 (Hynes Convention Center)

 

Contact our experts today to find out more about the work we are doing to support our customers’ projects, solving complex challenges, and bringing needed therapies to life.

Let’s discuss your project together.

schedule a meeting

 

 

 

 

 

Also in the Press Room

See All

Hovione is bringing momentum to the intranasal field after announcing that its lead single-use nasal dry powder device, developed in collaboration with Industrial Design Consultancy Ltd (IDC), is now available for commercial partnerships. The milestone marks the transition from prototype to a fully integrated intranasal drug delivery platform that spans Hovione’s end-to-end partnership capabilities–from API synthesis through advanced formulation and particle engineering to drug product manufacturing, including device supply and advanced analytical tools for nasal performance characterization. The platform’s single-use device is designed to be manufacturable at scale and to leverage existing advanced particle engineering and drug product manufacturing capabilities, a practical advantage that can shorten timelines to clinic and commercialization while reducing development risk and cost. The device’s patented mechanism supports targeted nasal deposition, including access to the upper olfactory region. This enables rapid systemic absorption and potential nose-to-brain delivery pathways that are increasingly important for CNS and emergency-use indications. Beyond the single-use format, Hovione and IDC are advancing a multi-dose variant to broaden applicability across dosing regimens and therapeutic areas. The collaboration is backed by an intellectual property portfolio and initial patent grants, positioning the platform as a turnkey option for pharma partners seeking a single integrated supplier for both drug substance and device. This development arrives as intranasal delivery gains traction for systemic, CNS and rapid-onset therapies. This is precisely the focus of the upcoming 4th Nasal Formulation & Delivery Summit, for which Hovione is a key sponsor. The annual summit unites formulation, delivery and product development leaders to tackle drug-device compatibility, translational preclinical models, and strategies for scalable, regulatory-ready intranasal programs. Hovione’s recent progress will be highly relevant to attendees looking to de-risk nose-to-brain and systemic intranasal programs. Read the full article at News-Medical.net    

Press Clipping

Hovione advances intranasal drug delivery with commercial-ready dry powder platform ahead of 4th Nasal Formulation & Delivery Summit

Jun 01, 2026